Neumora’s depression treatment hits phase 3 after nailing phase 2
An experimental antidepressant developed by Neumora Therapeutics has shown promising results in a phase 2 trial, leading the company to plan its pathway to phase 3 testing.
Archives for July 20, 2023
US startup bags $32 million to blend cancer surgery and immunotherapy
The U.S. startup Surge Therapeutics has raised $32 million in a Series B round to bankroll the development of a hydrogel-based immunotherapy delivered during cancer surgery.
Idorsia sells APAC businesses to Sosei Heptares for $466 million
The Swiss company Idorsia has sold its operating businesses Idorsia Pharmaceuticals Japan Ltd and Idorsia Pharmaceuticals Korea Co., Ltd to the Japanese firm Sosei Heptares for CHF 400 million ($466 million).
US startup bags $32 million to blend cancer surgery and immunotherapy
The U.S. startup Surge Therapeutics has raised $32 million in a Series B round to bankroll the development of a hydrogel-based immunotherapy delivered during cancer surgery.
Big pharma companies team up to increase diversity in genome data
The pharma giants AbbVie, Amgen, AstraZeneca, Bayer and Merck have been revealed as founding members of the Alliance for Genomic Discovery (AGD), a project aiming to accelerate drug development by collecting genomic data from underrepresented populations.